| |
| |
|
| Insider
Information: |
Polymeropoulos Mihael Hristos |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,871,730 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,789,148 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,871,730 |
|
|
| Total
Value |
$9,789,148 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
17
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -108.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
|
2024-03-05 |
1,871,730 |
2006-11-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-09-10 |
4 |
OE |
$4.73 |
$698,271 |
D/D |
147,626 |
918,943 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2011-08-22 |
4 |
B |
$5.34 |
$11,112 |
D/D |
2,080 |
382,080 |
2.81 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2011-08-23 |
4 |
B |
$5.35 |
$42,353 |
D/D |
7,920 |
390,000 |
2.81 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2023-03-02 |
4 |
S |
$6.23 |
$139,718 |
D/D |
(22,426) |
1,499,440 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2023-03-03 |
4 |
S |
$6.25 |
$140,876 |
D/D |
(22,538) |
1,476,902 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2010-12-10 |
4 |
S |
$8.10 |
$669,176 |
D/D |
(82,600) |
380,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2010-12-09 |
4 |
S |
$8.11 |
$141,100 |
D/D |
(17,400) |
462,600 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-11 |
4 |
OE |
$8.75 |
$365,899 |
D/D |
41,817 |
1,320,816 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-14 |
4 |
OE |
$8.75 |
$538,300 |
D/D |
61,520 |
1,347,283 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-15 |
4 |
OE |
$8.75 |
$408,301 |
D/D |
46,663 |
1,342,897 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2016-01-04 |
4 |
S |
$8.96 |
$191,323 |
D/D |
(21,353) |
839,178 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-05-21 |
4 |
S |
$10.33 |
$177,287 |
D/D |
(17,157) |
567,570 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-05-22 |
4 |
S |
$10.36 |
$1,754,050 |
D/D |
(169,238) |
758,147 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-03-10 |
4 |
S |
$10.53 |
$230,607 |
D/D |
(21,900) |
548,921 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-03-02 |
4 |
S |
$10.57 |
$110,211 |
D/D |
(10,428) |
1,284,151 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-06 |
4 |
S |
$10.61 |
$512,082 |
D/D |
(48,250) |
1,406,866 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-05 |
4 |
S |
$10.62 |
$506,200 |
D/D |
(47,650) |
1,379,751 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2019-12-11 |
4 |
OE |
$10.65 |
$949,969 |
D/D |
89,199 |
1,300,654 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2019-12-12 |
4 |
OE |
$10.65 |
$913,781 |
D/D |
85,801 |
1,314,082 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-03-03 |
4 |
S |
$10.98 |
$56,544 |
D/D |
(5,152) |
1,278,999 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-03-02 |
4 |
S |
$11.15 |
$329,945 |
D/D |
(29,588) |
1,352,766 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-03-01 |
4 |
S |
$11.19 |
$84,015 |
D/D |
(7,508) |
1,382,354 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2015-02-05 |
4 |
D |
$11.28 |
$281,402 |
D/D |
(24,947) |
527,071 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2006-11-06 |
4 |
S |
$11.70 |
$191,213 |
D/D |
(16,200) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chief Executive Officer |
• • – |
2006-11-07 |
4 |
S |
$11.70 |
$13,213 |
D/D |
(1,127) |
0 |
0 |
- |
|
111 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
